Global and China Sulphonamides Market Insights, Forecast to 2026

Publication ID:

QYR11201599

Publication Date:

November 23, 2020

Pages:

149

Publisher:

QYR

Region:

Global [1]

$3,900.00

Description:

Sulphonamides market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sulphonamides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Sulphonamides market is segmented into
Orally Absorbable Sulfonamide
Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

Segment by Application, the Sulphonamides market is segmented into
Skin Infections
Gastro Intestinal Tract (GIT) Infection
Meningitis

Regional and Country-level Analysis
The Sulphonamides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sulphonamides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Sulphonamides Market Share Analysis
Sulphonamides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Sulphonamides business, the date to enter into the Sulphonamides market, Sulphonamides product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories

Table Of Contents:

1 Study Coverage
1.1 Sulphonamides Product Introduction
1.2 Market Segments
1.3 Key Sulphonamides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sulphonamides Market Size Growth Rate by Type
1.4.2 Orally Absorbable Sulfonamide
1.4.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
1.4.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
1.5 Market by Application
1.5.1 Global Sulphonamides Market Size Growth Rate by Application
1.5.2 Skin Infections
1.5.3 Gastro Intestinal Tract (GIT) Infection
1.5.4 Meningitis
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Sulphonamides Market Size, Estimates and Forecasts
2.1.1 Global Sulphonamides Revenue 2015-2026
2.1.2 Global Sulphonamides Sales 2015-2026
2.2 Global Sulphonamides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Sulphonamides Historical Market Size by Region (2015-2020)
2.3.1 Global Sulphonamides Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Sulphonamides Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Sulphonamides Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Sulphonamides Sales Forecast by Region (2021-2026)
2.4.2 Global Sulphonamides Revenue Forecast by Region (2021-2026)

3 Global Sulphonamides Competitor Landscape by Players
3.1 Global Top Sulphonamides Sales by Manufacturers
3.1.1 Global Sulphonamides Sales by Manufacturers (2015-2020)
3.1.2 Global Sulphonamides Sales Market Share by Manufacturers (2015-2020)
3.2 Global Sulphonamides Manufacturers by Revenue
3.2.1 Global Sulphonamides Revenue by Manufacturers (2015-2020)
3.2.2 Global Sulphonamides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sulphonamides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sulphonamides Revenue in 2019
3.2.5 Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Sulphonamides Price by Manufacturers
3.4 Global Sulphonamides Manufacturing Base Distribution, Product Types
3.4.1 Sulphonamides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sulphonamides Product Type
3.4.3 Date of International Manufacturers Enter into Sulphonamides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Sulphonamides Market Size by Type (2015-2020)
4.1.1 Global Sulphonamides Sales by Type (2015-2020)
4.1.2 Global Sulphonamides Revenue by Type (2015-2020)
4.1.3 Sulphonamides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sulphonamides Market Size Forecast by Type (2021-2026)
4.2.1 Global Sulphonamides Sales Forecast by Type (2021-2026)
4.2.2 Global Sulphonamides Revenue Forecast by Type (2021-2026)
4.2.3 Sulphonamides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sulphonamides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Sulphonamides Market Size by Application (2015-2020)
5.1.1 Global Sulphonamides Sales by Application (2015-2020)
5.1.2 Global Sulphonamides Revenue by Application (2015-2020)
5.1.3 Sulphonamides Price by Application (2015-2020)
5.2 Sulphonamides Market Size Forecast by Application (2021-2026)
5.2.1 Global Sulphonamides Sales Forecast by Application (2021-2026)
5.2.2 Global Sulphonamides Revenue Forecast by Application (2021-2026)
5.2.3 Global Sulphonamides Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Sulphonamides Market Size YoY Growth 2015-2026
6.1.1 China Sulphonamides Sales YoY Growth 2015-2026
6.1.2 China Sulphonamides Revenue YoY Growth 2015-2026
6.1.3 China Sulphonamides Market Share in Global Market 2015-2026
6.2 China Sulphonamides Market Size by Players (International and Local Players)
6.2.1 China Top Sulphonamides Players by Sales (2015-2020)
6.2.2 China Top Sulphonamides Players by Revenue (2015-2020)
6.3 China Sulphonamides Historic Market Review by Type (2015-2020)
6.3.1 China Sulphonamides Sales Market Share by Type (2015-2020)
6.3.2 China Sulphonamides Revenue Market Share by Type (2015-2020)
6.3.3 China Sulphonamides Price by Type (2015-2020)
6.4 China Sulphonamides Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Sulphonamides Sales Forecast by Type (2021-2026)
6.4.2 China Sulphonamides Revenue Forecast by Type (2021-2026)
6.4.3 China Sulphonamides Price Forecast by Type (2021-2026)
6.5 China Sulphonamides Historic Market Review by Application (2015-2020)
6.5.1 China Sulphonamides Sales Market Share by Application (2015-2020)
6.5.2 China Sulphonamides Revenue Market Share by Application (2015-2020)
6.5.3 China Sulphonamides Price by Application (2015-2020)
6.6 China Sulphonamides Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Sulphonamides Sales Forecast by Application (2021-2026)
6.6.2 China Sulphonamides Revenue Forecast by Application (2021-2026)
6.6.3 China Sulphonamides Price Forecast by Application (2021-2026)

7 North America
7.1 North America Sulphonamides Market Size YoY Growth 2015-2026
7.2 North America Sulphonamides Market Facts & Figures by Country
7.2.1 North America Sulphonamides Sales by Country (2015-2020)
7.2.2 North America Sulphonamides Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Sulphonamides Market Size YoY Growth 2015-2026
8.2 Europe Sulphonamides Market Facts & Figures by Country
8.2.1 Europe Sulphonamides Sales by Country
8.2.2 Europe Sulphonamides Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Sulphonamides Market Size YoY Growth 2015-2026
9.2 Asia Pacific Sulphonamides Market Facts & Figures by Country
9.2.1 Asia Pacific Sulphonamides Sales by Region (2015-2020)
9.2.2 Asia Pacific Sulphonamides Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Sulphonamides Market Size YoY Growth 2015-2026
10.2 Latin America Sulphonamides Market Facts & Figures by Country
10.2.1 Latin America Sulphonamides Sales by Country
10.2.2 Latin America Sulphonamides Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Sulphonamides Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Sulphonamides Market Facts & Figures by Country
11.2.1 Middle East and Africa Sulphonamides Sales by Country
11.2.2 Middle East and Africa Sulphonamides Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Corporation Information
12.1.2 Abbott Laboratories Description and Business Overview
12.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Laboratories Sulphonamides Products Offered
12.1.5 Abbott Laboratories Recent Development
12.2 Boehringer Ingelheim Pharmaceuticals
12.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
12.2.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
12.2.3 Boehringer Ingelheim Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Products Offered
12.2.5 Boehringer Ingelheim Pharmaceuticals Recent Development
12.3 Bayer AG
12.3.1 Bayer AG Corporation Information
12.3.2 Bayer AG Description and Business Overview
12.3.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer AG Sulphonamides Products Offered
12.3.5 Bayer AG Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Description and Business Overview
12.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Sulphonamides Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 King Pharmaceuticals
12.5.1 King Pharmaceuticals Corporation Information
12.5.2 King Pharmaceuticals Description and Business Overview
12.5.3 King Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 King Pharmaceuticals Sulphonamides Products Offered
12.5.5 King Pharmaceuticals Recent Development
12.6 Mylan Pharmaceuticals
12.6.1 Mylan Pharmaceuticals Corporation Information
12.6.2 Mylan Pharmaceuticals Description and Business Overview
12.6.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Pharmaceuticals Sulphonamides Products Offered
12.6.5 Mylan Pharmaceuticals Recent Development
12.7 Novartis International AG
12.7.1 Novartis International AG Corporation Information
12.7.2 Novartis International AG Description and Business Overview
12.7.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novartis International AG Sulphonamides Products Offered
12.7.5 Novartis International AG Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Description and Business Overview
12.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Sulphonamides Products Offered
12.8.5 Pfizer Recent Development
12.9 Par Pharmaceutical
12.9.1 Par Pharmaceutical Corporation Information
12.9.2 Par Pharmaceutical Description and Business Overview
12.9.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Par Pharmaceutical Sulphonamides Products Offered
12.9.5 Par Pharmaceutical Recent Development
12.10 Roche Holding AG
12.10.1 Roche Holding AG Corporation Information
12.10.2 Roche Holding AG Description and Business Overview
12.10.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Roche Holding AG Sulphonamides Products Offered
12.10.5 Roche Holding AG Recent Development
12.11 Abbott Laboratories
12.11.1 Abbott Laboratories Corporation Information
12.11.2 Abbott Laboratories Description and Business Overview
12.11.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abbott Laboratories Sulphonamides Products Offered
12.11.5 Abbott Laboratories Recent Development
12.12 Stiefel Laboratories
12.12.1 Stiefel Laboratories Corporation Information
12.12.2 Stiefel Laboratories Description and Business Overview
12.12.3 Stiefel Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Stiefel Laboratories Products Offered
12.12.5 Stiefel Laboratories Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sulphonamides Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Sulphonamides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Boehringer Ingelheim Pharmaceuticals
Bayer AG
GlaxoSmithKline
King Pharmaceuticals
Mylan Pharmaceuticals
Novartis International AG
Pfizer
Par Pharmaceutical
Roche Holding AG
Sanofi Aventis
Stiefel Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.